|Bid||108.82 x 800|
|Ask||108.75 x 1300|
|Day's range||107.15 - 108.94|
|52-week range||79.11 - 121.53|
|Beta (5Y monthly)||0.83|
|PE ratio (TTM)||29.33|
|Forward dividend & yield||5.20 (4.80%)|
|Ex-dividend date||14 Oct 2021|
|1y target est||N/A|
Resmed (NYSE: RMD), Walgreens Boots Alliance (NASDAQ: WBA) and AbbVie (NYSE: ABBV) are profitable companies that have clear paths to future revenue growth. ResMed is already an industry leader in sleep apnea therapies, an area that's expected to grow as our population ages. Walgreens Boots Alliance is jumping onto the trend toward value-oriented healthcare services, and AbbVie's huge stable of drugs and pipeline give it a diversity that protects its long-term outlook.
AbbVie (ABBV) closed the most recent trading day at $107.43, moving -1.74% from the previous trading session.
Admittedly, I don't have many stocks in my portfolio that pay high dividend yields. My positions tend to focus more on growth than on dividends. AbbVie (NYSE: ABBV) is only one dividend increase away from becoming a Dividend King -- S&P 500 members with at least 50 consecutive years of dividend increases.